Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 1.72% is 115% above its 5-year average of -11.77%, near the high end of its 5-year range (-38.00%–1.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 163.35% above its 12-month average of -2.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 1.72%.
RETURN ON INVESTED CAPITAL (ROIC)
1.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-2.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-7.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-11.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-8.98%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-18.16%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
-19.86%
CURRENT VS TTM AVG
+163.35%
CURRENT VS 3Y AVG
+122.00%
CURRENT VS 5Y AVG
+114.61%
CURRENT VS 10Y AVG
+119.15%
CURRENT VS 15Y AVG
+109.47%
CURRENT VS 20Y AVG
+108.66%
SECTOR MEDIAN · HEALTHCARE
-31.17%
median of 543 covered companies
CURRENT VS SECTOR MEDIAN
+105.52%
vs the sector median at left
BioLife Solutions, Inc.
Market Cap
$1.89B
Return on Invested Capital (ROIC)
1.72%
TTM Avg
-2.71%
3Y Avg
-7.82%
5Y Avg
-11.77%
Market Cap
$1.87B
Return on Invested Capital (ROIC)
-44.21%
TTM Avg
-32.05%
3Y Avg
-35.56%
5Y Avg
-35.59%
Market Cap
$1.85B
Return on Invested Capital (ROIC)
4.13%
TTM Avg
4.21%
3Y Avg
5.71%
5Y Avg
5.17%
Market Cap
$1.93B
Return on Invested Capital (ROIC)
-52.66%
TTM Avg
-61.09%
3Y Avg
-54.75%
5Y Avg
-42.45%
Market Cap
$1.83B
Return on Invested Capital (ROIC)
9.81%
TTM Avg
8.38%
3Y Avg
8.16%
5Y Avg
8.82%
Market Cap
$1.96B
Return on Invested Capital (ROIC)
-6.53%
TTM Avg
-15.76%
3Y Avg
-21.33%
5Y Avg
-21.68%
Market Cap
$1.81B
Return on Invested Capital (ROIC)
-54.45%
TTM Avg
-54.60%
3Y Avg
-46.39%
5Y Avg
-38.46%
Market Cap
$1.99B
Return on Invested Capital (ROIC)
-51.06%
TTM Avg
-99.01%
3Y Avg
-126.31%
5Y Avg
-97.79%
Market Cap
$2.01B
Return on Invested Capital (ROIC)
-4.68%
TTM Avg
-2.93%
3Y Avg
-9.02%
5Y Avg
-10.48%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioLife Solutions, Inc. (BLFS) | $1.89B | 1.72% | -2.71% | -7.82% | -11.77% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | -44.21% | -32.05% | -35.56% | -35.59% |
| Astrana Health, Inc. (ASTH)vs › | $1.85B | 4.13% | 4.21% | 5.71% | 5.17% |
| Absci Corporation (ABSI)vs › | $1.93B | -52.66% | -61.09% | -54.75% | -42.45% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.83B | 9.81% | 8.38% | 8.16% | 8.82% |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | -6.53% | -15.76% | -21.33% | -21.68% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.81B | -54.45% | -54.60% | -46.39% | -38.46% |
| Immunome, Inc. (IMNM)vs › | $1.99B | -51.06% | -99.01% | -126.31% | -97.79% |
| AxoGen, Inc. (AXGN)vs › | $2.01B | -4.68% | -2.93% | -9.02% | -10.48% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.76B | -94.79% | -70.21% | -70.21% | -70.21% |
ROIC
1.7%
ROE
12.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | 1.72% |
| 2026-03-31 | -2.83% |
| 2025-12-31 | -3.13% |
| 2025-09-30 | -4.45% |
| 2025-06-30 | -4.89% |
| 2025-03-31 | -0.71% |
| 2024-12-31 | -1.26% |
| 2024-09-30 | -5.34% |
| 2024-06-30 | -9.37% |
| 2024-03-31 | -11.45% |
| 2023-12-31 | -14.03% |
| 2023-09-30 | -24.08% |
| 2023-06-30 | -21.80% |
| 2023-03-31 | -38.00% |
| 2022-12-31 | -35.96% |
| 2022-09-30 | -24.91% |
| 2022-06-30 | -25.59% |
| 2022-03-31 | -8.03% |
| 2021-12-31 | -6.62% |
| 2021-09-30 | -4.04% |
| 2021-06-30 | -2.31% |
| 2021-03-31 | -3.08% |
| 2020-12-31 | -2.54% |
| 2020-09-30 | -0.75% |
| 2020-06-30 | -0.88% |
| 2020-03-31 | -0.34% |
| 2019-12-31 | -0.05% |
| 2019-09-30 | 2.00% |
| 2019-06-30 | 7.30% |
| 2019-03-31 | 9.01% |
| 2018-12-31 | 4.66% |
| 2018-09-30 | 2.98% |
| 2018-06-30 | 5.83% |
| 2018-03-31 | -4.11% |
| 2017-12-31 | -9.93% |
| 2017-09-30 | -18.80% |
| 2017-06-30 | -34.56% |
| 2017-03-31 | -50.88% |
| 2016-12-31 | -71.40% |
| 2016-09-30 | -62.18% |
| 2016-06-30 | -64.71% |
| 2016-03-31 | -57.54% |
| 2015-12-31 | -47.14% |
| 2014-09-30 | -18.00% |
| 2014-06-30 | -11.64% |
| 2014-03-31 | -5.68% |
| 2013-12-31 | -16.54% |
| 2013-09-30 | -15.58% |
| 2013-06-30 | -17.22% |
| 2013-03-31 | -29.33% |
| 2012-12-31 | -52.22% |
| 2012-09-30 | -43.35% |
| 2012-06-30 | -47.92% |
| 2012-03-31 | -79.12% |
| 2011-12-31 | -111.72% |
| 2011-09-30 | -126.09% |
| 2011-06-30 | -136.52% |
| 2011-03-31 | -157.70% |
| 2010-12-31 | -143.98% |
| 2009-12-31 | -234.05% |
| 2009-09-30 | -1094.28% |
| 2008-06-30 | -459.29% |
| 2006-12-31 | -395819.26% |
| 2006-09-30 | -356.14% |
| 2006-06-30 | -148.67% |
| 2006-03-31 | -1139.43% |
| 2005-12-31 | -237.33% |
| 2005-09-30 | -109.83% |
| 2005-06-30 | -170.55% |
| 2005-03-31 | -123.24% |
| 2004-12-31 | -107.42% |
| 2004-09-30 | -122.95% |
| 2004-06-30 | -147.78% |
| 2004-03-31 | -138.54% |
| 2003-12-31 | -76.77% |
